Xiaojin Liu
- Hepatology top 10%
-
- interferon and immune responses 2
-
- Cancer-related molecular mechanisms research 2
-
- Pituitary Gland Disorders and Treatments 3
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
-
- Extracellular vesicles in disease 2
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
-
- Infectious Diseases and Mycology 2
- Cited by
- HepatologyImmunologyCancer Research
- Partner nations
- ChinaGermanyUnited Kingdom
In The Last Decade
Xiaojin Liu
24 papers receiving 577 citations
Peers
Comparison fields: 5 of 87
- Hepatology 81
- Immunology 158
- Cancer Research 77
- Pharmacology 86
- Biotechnology 34
Countries citing papers authored by Xiaojin Liu
This map shows the geographic impact of Xiaojin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojin Liu more than expected).
Fields of papers citing papers by Xiaojin Liu
This network shows the impact of papers produced by Xiaojin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojin Liu. The network helps show where Xiaojin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 47 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 35 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 22 | |
| 17 | 2018 | 5 | |
| 18 | 2013 | 50 | |
| 19 | 2012 | 59 | |
| 20 | 2009 | 164 |
About Xiaojin Liu
Xiaojin Liu is a scholar working on Microbiology, Cancer Research and Immunology, having authored 26 papers that have together received 585 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (3 papers), interferon and immune responses (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Cancer-related molecular mechanisms research (2 papers), Extracellular vesicles in disease (2 papers), RNA modifications and cancer (2 papers), Infectious Diseases and Mycology (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Hepatology (81 citations), Immunology (158 citations) and Cancer Research (77 citations). Xiaojin Liu has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Mingcai Li, Yanchun Zhou, Shao Bo Su, Zhigang Zhang, Yiwei Qi, Min‐Juan Xu, Guoying Zhang, Chuan Qiu, Min Li and Yan Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.